Posted by Michael Wonder on 17 Oct 2025
Merck announces unprecedented agreement with US Government to expand access to IVF therapies
16 October 2025 - Merck announced today that EMD Serono, the healthcare business of Merck in the US and Canada, and US President Donald J. Trump’s administration entered into an agreement to expand access to EMD Serono’s portfolio of in vitro fertilisation (IVF) therapies for the more than 10 million American women struggling to have a baby.
As part of the agreement, EMD Serono will offer direct to consumer sales of its complete portfolio of IVF therapies, including Gonal-f (follitropin alfa injection), Ovidrel (choriogonadotropin alfa injection), and Cetrotide (cetrorelix acetate for injection), to eligible patients with prescriptions at significantly reduced prices.
